DREAMing Beyond Stage IVA: Lung Transplantation and Molecular Surveillance for Lung-Confined NSCLC

Dr. Lampert Case Study: Early Experience with Single-Donor Fraction Threshold

Dr. Lampert Case Study: Markedly Elevated dd-cfDNA % and DQS

Dr. Lampert Case Study: Markedly Elevated dd-cfDNA % and DQS. Prospera™ results after 2nd heart transplant

Dr. Lampert Case Study: Elevated dd-cfDNA % and Normal DQS

Prospera in Practice: Dr. Lampert

ATC 2026 Prospera Symposium: From Promise to Practice

Cell-Free DNA: From Promise to Practice—How Far We’ve Come This symposium explored from the foundation to the frontier of donor-derived cell-free DNA technology. Featuring expert perspectives, this se

Prospera in Practice Lung Dr. Rohit Gupta and Dr. Samir Sultan

ISHLT 2026 Heart Symposium - Dr. Palak Shah

From insight to action: Integrating cell-free DNA testing into daily transplant care

Prospera Case Study Video- Dr. Lodhi

QAPI Overview- Dr. Rosenheck

The PEDAL Study: Prospera dd-cfDNA use in post-rejection monitoring

Redefining heart transplant care: How donor-derived cell-free DNA is transforming rejection surveillance

This webinar highlights the DEFINE-HT study initial results and the two-threshold algorithm: fraction + DQS.

Prospera in Practice: Nursing Strategies for "High-risk" Results